Announcement on Voluntary Disclosure of Subsidiary’s YKYY032 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration and FDA

About this update from Youcare Pharmaceutical Group Co. Ltd. Class A

Announcement on Voluntary Disclosure of Subsidiary’s YKYY032 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration and FDA The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Youcare Pharmaceutical Group Co. Ltd. Class A